Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
- 1 March 2009
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 55 (3), 407-419
- https://doi.org/10.1373/clinchem.2008.118356
Abstract
Background: Low-density lipoprotein cholesterol (LDL-C) has been the cornerstone measurement for assessing cardiovascular risk for nearly 20 years.Content: Recent data demonstrate that apolipoprotein B (apo B) is a better measure of circulating LDL particle number (LDL-P) concentration and is a more reliable indicator of risk than LDL-C, and there is growing support for the idea that addition of apo B measurement to the routine lipid panel for assessing and monitoring patients at risk for cardiovascular disease (CVD) would enhance patient management. In this report, we review the studies of apo B and LDL-P reported to date, discuss potential advantages of their measurement over that of LDL-C, and present information related to standardization.Conclusions: In line with recently adopted Canadian guidelines, the addition of apo B represents a logical next step to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII) and other guidelines in the US. Considering that it has taken years to educate physicians and patients regarding the use of LDL-C, changing perceptions and practices will not be easy. Thus, it appears prudent to consider using apo B along with LDL-C to assess LDL-related risk for an interim period until the superiority of apo B is generally recognized.Keywords
Funding Information
- NIH
This publication has 72 references indexed in Scilit:
- Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart DiseaseThe American Journal of Cardiology, 2008
- Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practiceJournal of Clinical Lipidology, 2008
- LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL managementJournal of Clinical Lipidology, 2007
- Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial diseaseAtherosclerosis, 2007
- Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein BArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Value of Low-Density Lipoprotein Particle Number and Size as Predictors of Coronary Artery Disease in Apparently Healthy Men and WomenJournal of the American College of Cardiology, 2007
- Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysisHuman Genetics, 2003
- IntroductionThe American Journal of Cardiology, 2002
- The Amino Terminus of Apolipoprotein B Is Necessary but Not Sufficient for Microsomal Triglyceride Transfer Protein ResponsivenessPublished by Elsevier BV ,1996
- Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 1995